Form 4 for IRWD IRONWOOD PHARMACEUTICALS INC
Accepted 2022-03-02 00:00:00 ET · period of report 2022-02-28 · accession 0001209191-22-014661 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-03-02 | 2022-02-28 | IRWD | Silver Ronald | Principal Accounting Off | S - Sale | $10.77 | -2,238 | 63.0K | -3% | -$24.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-02-28 | S | D | 1,150 | $10.77 | 61,211 | D | — | — | |
| 2 | Common | Class A Common Stock | 2022-02-28 | S | D | 640 | $10.77 | 62,361 | D | — | — | |
| 3 | Common | Class A Common Stock | 2022-02-28 | S | D | 448 | $10.77 | 63,001 | D | — | — | (F2) The reporting person acquired 2,236 shares of Class A Common Stock under the issuer's employee stock purchase plan on June 30, 2021. |